US Patent Issued to Prilenia Neurotherapeutics on Aug. 18 for "Use of pridopidine for treating anxiety and depression" (Israeli Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,619, issued on Aug. 18, was assigned to Prilenia Neurotherapeutics Ltd. (Yakum, Israel).

"Use of pridopidine for treating anxiety and depression" was invented by Michael Hayden (Yakum, Israel) and Michal Geva (Even-Yehuda, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides a method of treating depression or anxiety in a human subject by administering a composition comprising pridopidine or a pharmaceutically acceptable salt thereof."

The patent was filed on Oct. 17, 2022, under Application No. 17/967,415.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parse...